Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
642,952
-
Share change
-
+14,983
-
Total reported value
-
$7,200,000
-
Price per share
-
$11.20
-
Number of holders
-
9
-
Value change
-
+$371,552
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2022
As of 30 Jun 2022,
Nuvectis Pharma, Inc. - COM (NVCT) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
642,952 shares.
The largest 9 holders included
Ronit Capital LLP, BALDWIN BROTHERS LLC/MA, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., Tower Research Capital LLC (TRC), and MORGAN STANLEY.
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.